Multiple Sclerosis Trial, Recruiting (NCT07549048)

Multiple Sclerosis Trial, Recruiting NCT07549048 Sponsor: Istanbul Physical Medicine Rehabilitation Training and Research Hospital Condition: Multiple Sclerosis

Printed from Voxsanity (voxsanity.com.au) — NCT07549048 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Multiple Sclerosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 18 and 80 years old
A neurologist has officially diagnosed you with multiple sclerosis
You are currently receiving care at a physical therapy and rehabilitation clinic during the study period
You have a family member who acts as your main or regular caregiver
Both you and your caregiver are able to read, understand, and complete questionnaires written in Turkish
You are willing to take part and sign a consent form agreeing to participate

Who may not be able to join:

You have severe difficulties with thinking, memory, or communication that would make it impossible to complete questionnaires
You have had a sudden worsening of your MS symptoms (a relapse) or been hospitalised for this in the past month
You have another serious neurological, psychiatric, or physical health condition that could affect the study results
Your caregiver is under 18 years old or does not provide care on a regular basis
Your caregiver is a paid professional carer rather than a family member
Your caregiver has a serious psychiatric, neurological, or sleep condition of their own
You or your caregiver do not wish to take part

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07549048

Sponsor: Istanbul Physical Medicine Rehabilitation Training and Research Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Multiple Sclerosis

More information: https://clinicaltrials.gov/study/NCT07549048

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 18 and 80 years old
A neurologist has officially diagnosed you with multiple sclerosis
You are currently receiving care at a physical therapy and rehabilitation clinic during the study period
You have a family member who acts as your main or regular caregiver
Both you and your caregiver are able to read, understand, and complete questionnaires written in Turkish
You are willing to take part and sign a consent form agreeing to participate

Who may not be able to join:

You have severe difficulties with thinking, memory, or communication that would make it impossible to complete questionnaires
You have had a sudden worsening of your MS symptoms (a relapse) or been hospitalised for this in the past month
You have another serious neurological, psychiatric, or physical health condition that could affect the study results
Your caregiver is under 18 years old or does not provide care on a regular basis
Your caregiver is a paid professional carer rather than a family member
Your caregiver has a serious psychiatric, neurological, or sleep condition of their own
You or your caregiver do not wish to take part

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Istanbul Physical Medicine Rehabilitation Training and Research Hospital

Registry

ClinicalTrials.gov

Start date

20 April 2026

Est. completion

20 May 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Zarit Caregiver Burden Scale (Zarit Burden Interview, ZBI)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov